Literature DB >> 26886346

Acetate- and Citrate-Specific Ion Effects on Unfolding and Temperature-Dependent Aggregation Rates of Anti-Streptavidin IgG1.

Gregory V Barnett1, Vladimir I Razinkov2, Bruce A Kerwin2, Alexander Hillsley1, Christopher J Roberts3.   

Abstract

Controlling and predicting unwanted degradation, such as non-native aggregation, is a long-standing challenge for mAbs and other protein-based products. mAb aggregation rates are typically sensitive to temperature, pH, and the addition of excipients. Quantitatively comparing temperature-dependent aggregation rates across multiple possible formulations is a challenge in product development. A parallel temperature initial rate method is used to efficiently and accurately determine initial rates for anti-streptavidin (AS) IgG1 aggregation as a function of pH, [NaCl], and in the presence of acetate versus citrate buffer. Parallel temperature initial rates are shown to agree with results from a traditional, isothermal method and permits direct comparison of the formulations across almost 3 orders of magnitude of aggregation rates. The apparent midpoint unfolding temperatures (through differential scanning calorimetry) and the effective activation energy values (Ea) are generally higher in acetate buffer compared with citrate buffer, which is consistent with preferential accumulation of citrate ions compared with acetate ions that was speculated in previous work (Barnett et al., J Phys Chem B, 2015). Static light scattering and Kirkwood-Buff analysis show that AS-IgG1 has stronger net repulsive protein-protein interactions in acetate compared with citrate buffer, also consistent with increased values of Ea. In an extreme case, aggregation of AS-IgG1 is effectively eliminated across all practical temperatures at pH 4 in 10 mM sodium acetate but proceeds readily in citrate buffer.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  calorimetry (DSC); formulation; high-performance liquid chromatography; protein aggregation; stability

Mesh:

Substances:

Year:  2016        PMID: 26886346     DOI: 10.1016/j.xphs.2015.12.017

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

1.  Predicting Protein-Protein Interactions of Concentrated Antibody Solutions Using Dilute Solution Data and Coarse-Grained Molecular Models.

Authors:  Cesar Calero-Rubio; Ranendu Ghosh; Atul Saluja; Christopher J Roberts
Journal:  J Pharm Sci       Date:  2017-12-21       Impact factor: 3.534

2.  Parallel chromatography and in situ scattering to interrogate competing protein aggregation pathways.

Authors:  Diana Gomes; Rebecca K Kalman; Rebecca K Pagels; Miguel A Rodrigues; Christopher J Roberts
Journal:  Protein Sci       Date:  2018-06-13       Impact factor: 6.725

3.  L445P mutation on heavy chain stabilizes IgG4 under acidic conditions.

Authors:  Chang-Ai Xu; Andrew Z Feng; Charan K Ramineni; Matthew R Wallace; Elizabeth K Culyba; Kevin P Guay; Kinjal Mehta; Robert Mabry; Stephen Farrand; Jin Xu; Jianwen Feng
Journal:  MAbs       Date:  2019-07-11       Impact factor: 5.857

4.  Heterotropic Modulation of Amylin Fibrillation by Small Molecules: Implications for Formulative Designs.

Authors:  Celimar Sinézia; Luís Maurício T R Lima
Journal:  Protein J       Date:  2020-02       Impact factor: 2.371

5.  Expanding the toolbox for predictive parameters describing antibody stability considering thermodynamic and kinetic determinants.

Authors:  Michaela Blech; Richard Melien; Nuska Tschammer; Beate Presser; Dariush Hinderberger; Patrick Garidel
Journal:  Pharm Res       Date:  2021-12-13       Impact factor: 4.200

6.  Identifying protein aggregation mechanisms and quantifying aggregation rates from combined monomer depletion and continuous scattering.

Authors:  Gregory V Barnett; Michael Drenski; Vladimir Razinkov; Wayne F Reed; Christopher J Roberts
Journal:  Anal Biochem       Date:  2016-08-07       Impact factor: 3.365

7.  Biochemical and structural characterization of a novel halotolerant cellulase from soil metagenome.

Authors:  Roma Garg; Ritika Srivastava; Vijaya Brahma; Lata Verma; Subramanian Karthikeyan; Girish Sahni
Journal:  Sci Rep       Date:  2016-12-23       Impact factor: 4.379

8.  Stability enhancement in a mAb and Fab coformulation.

Authors:  Hongyu Zhang; Paul A Dalby
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

Review 9.  Advancements in the co-formulation of biologic therapeutics.

Authors:  Veeren M Chauhan; Hongyu Zhang; Paul A Dalby; Jonathan W Aylott
Journal:  J Control Release       Date:  2020-08-14       Impact factor: 9.776

10.  Automated High-Throughput Capillary Circular Dichroism and Intrinsic Fluorescence Spectroscopy for Rapid Determination of Protein Structure.

Authors:  Charles Moore-Kelly; John Welsh; Alison Rodger; Tim R Dafforn; Owen R T Thomas
Journal:  Anal Chem       Date:  2019-10-17       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.